SOPHiA GENETICS SA SOPH Stock
SOPHiA GENETICS SA Price Chart
SOPHiA GENETICS SA SOPH Financial and Trading Overview
| SOPHiA GENETICS SA stock price | 5.23 USD |
| Previous Close | 5.46 USD |
| Open | 5.3 USD |
| Bid | 3.91 USD x 200 |
| Ask | 6.82 USD x 200 |
| Day's Range | 5.24 - 5.59 USD |
| 52 Week Range | 2.81 - 5.7 USD |
| Volume | 354.58K USD |
| Avg. Volume | 135.96K USD |
| Market Cap | 448M USD |
| Beta (5Y Monthly) | 0.985 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.18 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8 USD |
SOPH Valuation Measures
| Enterprise Value | 380.39M USD |
| Trailing P/E | N/A |
| Forward P/E | -9.535714 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.5186095 |
| Price/Book (mrq) | 8.396227 |
| Enterprise Value/Revenue | 4.686 |
| Enterprise Value/EBITDA | -5.409 |
Trading Information
SOPHiA GENETICS SA Stock Price History
| Beta (5Y Monthly) | 0.985 |
| 52-Week Change | 69.52% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 5.7 USD |
| 52 Week Low | 2.81 USD |
| 50-Day Moving Average | 5.02 USD |
| 200-Day Moving Average | 4.67 USD |
SOPH Share Statistics
| Avg. Volume (3 month) | 135.96K USD |
| Avg. Daily Volume (10-Days) | 377.62K USD |
| Shares Outstanding | 83.9M |
| Float | 51.74M |
| Short Ratio | 2.93 |
| % Held by Insiders | 7.24% |
| % Held by Institutions | 48.80% |
| Shares Short | 279.1K |
| Short % of Float | 0.41% |
| Short % of Shares Outstanding | 0.38% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -99.69% |
| Operating Margin (ttm) | -79.68% |
| Gross Margin | 67.28% |
| EBITDA Margin | -86.62% |
Management Effectiveness
| Return on Assets (ttm) | -29.70% |
| Return on Equity (ttm) | -123.28% |
Income Statement
| Revenue (ttm) | 81.18M USD |
| Revenue Per Share (ttm) | 1.18 USD |
| Quarterly Revenue Growth (yoy) | 22.00% |
| Gross Profit (ttm) | 54.62M USD |
| EBITDA | -70322000 USD |
| Net Income Avi to Common (ttm) | -80936000 USD |
| Diluted EPS (ttm) | -1.18 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 65.39M USD |
| Total Cash Per Share (mrq) | 0.91 USD |
| Total Debt (mrq) | 62.43M USD |
| Total Debt/Equity (mrq) | 136.63 USD |
| Current Ratio (mrq) | 2.056 |
| Book Value Per Share (mrq) | 0.636 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -40263000 USD |
| Levered Free Cash Flow (ttm) | -24592376 USD |
Profile of SOPHiA GENETICS SA
| Country | United States |
| State | N/A |
| City | Rolle |
| Address | La PiEce 12 |
| ZIP | 1180 |
| Phone | 41 21 694 10 60 |
| Website | https://www.sophiagenetics.com |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 415 |
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.
Q&A For SOPHiA GENETICS SA Stock
What is a current SOPH stock price?
SOPHiA GENETICS SA SOPH stock price today per share is 5.23 USD.
How to purchase SOPHiA GENETICS SA stock?
You can buy SOPH shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SOPHiA GENETICS SA?
The stock symbol or ticker of SOPHiA GENETICS SA is SOPH.
Which industry does the SOPHiA GENETICS SA company belong to?
The SOPHiA GENETICS SA industry is Health Information Services.
How many shares does SOPHiA GENETICS SA have in circulation?
The max supply of SOPHiA GENETICS SA shares is 83.9M.
What is SOPHiA GENETICS SA Price to Earnings Ratio (PE Ratio)?
SOPHiA GENETICS SA PE Ratio is now.
What was SOPHiA GENETICS SA earnings per share over the trailing 12 months (TTM)?
SOPHiA GENETICS SA EPS is -1.18 USD over the trailing 12 months.
Which sector does the SOPHiA GENETICS SA company belong to?
The SOPHiA GENETICS SA sector is Healthcare.
SOPHiA GENETICS SA SOPH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
12546.99 USD — |
-2.24
|
— — | 12513.27 USD — | 12692.24 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}